Literature DB >> 1591048

Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF-receptor positive human ovarian carcinoma cell lines.

A J Crew1, S P Langdon, E P Miller, W R Miller.   

Abstract

The role of epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha) in the growth modulation of three human ovarian adenocarcinoma cell lines, PEO1, PEO4 and PEO14, has been examined by measuring responses of the cells growing in monolayer culture to exogenous addition of the growth factors. The presence of EGF receptors in the cell lines has been confirmed by ligand binding and immunocytochemical staining using a monoclonal antibody directed against the EGF receptor. The growth of all three cell lines was stimulated by both EGF and TGF-alpha. Dose-response effects were noted with the greatest growth stimulation occurring at concentrations between 0.1 and 10 nmol/l. The stimulatory effects of EGF and TGF-alpha were accompanied by changes in the cell cycle distribution as detected by flow cytometric analysis. It is concluded that EGF and TGF-alpha are important growth regulators in these EGF-receptor positive ovarian cancer cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591048     DOI: 10.1016/s0959-8049(05)80049-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

Review 1.  Activated epidermal growth factor receptor in ovarian cancer.

Authors:  Laurie G Hudson; Reema Zeineldin; Melina Silberberg; M Sharon Stack
Journal:  Cancer Treat Res       Date:  2009

2.  Absence of constitutive EGF receptor activation in ovarian cancer cell lines.

Authors:  C Ottensmeier; L Swanson; T Strobel; B Druker; J Niloff; S A Cannistra
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

3.  Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa").

Authors:  J M Sewell; K G Macleod; A Ritchie; J F Smyth; S P Langdon
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

4.  Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868.

Authors:  B J Simpson; J M Bartlett; K G Macleod; G Rabiasz; E P Miller; A L Rae; P Gordge; R E Leake; W R Miller; J Smyth; S P Langdon
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

Review 5.  The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer.

Authors:  Sudha S Savant; Shruthi Sriramkumar; Heather M O'Hagan
Journal:  Cancers (Basel)       Date:  2018-07-30       Impact factor: 6.639

6.  The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.

Authors:  J M Bartlett; S P Langdon; B J Simpson; M Stewart; D Katsaros; P Sismondi; S Love; W N Scott; A R Williams; A M Lessells; K G Macleod; J F Smyth; W R Miller
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.